4.7 Article

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study

Journal

SCIENTIFIC REPORTS
Volume 7, Issue -, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/srep40646

Keywords

-

Ask authors/readers for more resources

The clinical role of vitamin D in sepsis and mortality prediction is controversially discussed. Therefore, we conducted a prospective cohort study on standard care wards, including 461 patients with suspected sepsis fulfilling two or more SIRS criteria. On the first and third day after onset of SIRS symptoms levels of 25(OH) D, 1,25(OH) D and sepsis biomarkers were analysed for their predictive capacity for identifying infection, bacteraemia and an elevated mortality risk. Additionally, several SNPs associated with vitamin D metabolism were evaluated. Bacteraemic patients (28.5%) presented with significantly lower 1,25(OH) D levels than SIRS patients without bacteraemia on the first and third day, while 25(OH) D did not show a predictive capacity. No significant differences of either 1,25(OH) D or 25(OH) D levels were found between SIRS patients with and without infections or between survivors and non-survivors. Sepsis biomarkers, including procalcitonin and CRP, showed a significantly higher discriminatory capacity for these classification tasks. The vitamin D metabolism-related SNPs analysed did not indicate any association with our outcome measures. In conclusion, 1,25(OH) D but not 25(OH) D showed a minor discriminatory value for the prediction of bacteraemia that was inferior to CRP and PCT but both failed to predict sepsis and mortality in a prospective cohort of SIRS patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls

Felix Kartnig, Daniel Mrak, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, Lisa Goeschl, Nikolaus Hommer, Margareta Mayer, Philipp Hofer, Thomas Hummel, Thomas Deimel, Irina Gessl, Antonia Puchner, Andreas Kerschbaumer, Renate Thalhammer, Alessandra Handisurya, Renate Kain, Stefan Winkler, Josef S. Smolen, Karin Stiasny, Thomas Perkmann, Helmuth Haslacher, Judith H. Aberle, Daniel Aletaha, Leonhard X. Heinz, Daniela Sieghart, Michael Bonelli

Summary: This clinical trial evaluated the immunogenicity and safety of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases (IMIDs). The results showed that the third vaccination had good immunogenicity and safety in these patients, but the effects of immunomodulatory therapy should be considered.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Immunology

Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases

Daniel Mrak, Felix Kartnig, Daniela Sieghart, Elisabeth Simader, Helga Radner, Peter Mandl, Lisa Goeschl, Philipp Hofer, Thomas Deimel, Irina Gessl, Renate Kain, Stefan Winkler, Josef S. Smolen, Thomas Perkmann, Helmuth Haslacher, Daniel Aletaha, Leonhard X. Heinz, Michael Bonelli

Summary: A study found that patients under immunosuppression experienced a rapid decline in antibodies after the third COVID-19 vaccine dose, and it remains unclear whether immunosuppressive therapy affects immune responses. Monitoring the immune response and adverse events in 50 immunosuppressed patients and 42 healthy controls, it was observed that immunosuppressed patients had significantly lower antibody levels, suggesting the need for an early fourth vaccination.

JOURNAL OF AUTOIMMUNITY (2023)

Article Virology

Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology

Thomas Perkmann, Patrick Mucher, Darlene Oesze, Antonia Mueller, Nicole Perkmann-Nagele, Thomas Koller, Astrid Radakovics, Ines Flieder, Manuela Repl, Rodrig Marculescu, Michael Wolzt, Oswald F. Wagner, Christoph J. Binder, Helmuth Haslacher

Summary: This study investigated the comparability of WHO standard referenced commercial SARS-CoV-2 antibody tests after three doses of BNT162b2 vaccine for up to 14 months. The results showed systematic differences between the results of the three antibody binding assays, but the differences decreased over time. IgG-based assays had better agreement with each other but were not interchangeable with the Roche assay. In conclusion, standardization of SARS-CoV-2 antibody binding assays needs improvement for reliable longitudinal analysis.

JOURNAL OF CLINICAL VIROLOGY (2023)

Article Medicine, General & Internal

Comparison of the prevalence of SARS-CoV-2 nucleoprotein antibodies in healthcare workers and an unselected adult and paediatric all-comer patient population: insights from a longitudinal study of healthcare workers and concurrent serial cross-sectional studies of patients at an academic medical centre in Austria

Martin Riesenhuber, Christian Nitsche, Christoph J. Binder, Eva S. Schernhammer, Tanja Stamm, Friedrich Jakse, Elaaha Anwari, Fardin Hamidi, Helmuth Haslacher, Thomas Perkmann, Christian Hengstenberg, Thomas A. Zelniker

Summary: This study aimed to estimate and compare the prevalence of anti-SARS-CoV-2 N antibodies in healthcare workers and patients. The results showed that healthcare workers and patients had similar and higher seroprevalence compared to confirmed cases in Austria throughout the pandemic. There was no significant difference in seroprevalence between pediatric and adult patients at different time periods.

BMJ OPEN (2023)

Article Substance Abuse

Can thiamine substitution restore cognitive function in alcohol use disorder?

Stephan Listabarth, Benjamin Vyssoki, Rodrig Marculescu, Andreas Gleiss, Magdalena Groemer, Armin Trojer, Christine Harrer, Sabine Weber, Daniel Koenig

Summary: This study aimed to compare the effect of two best practice thiamine substitution regimens on thiamine blood levels and cognitive function. The results showed that increases in thiamine levels were associated with pronounced improvements of cognitive function, and oral and intravenous substitution seemed to be equally effective.

ALCOHOL AND ALCOHOLISM (2023)

Article Nutrition & Dietetics

Association between salt intake and gastric atrophy by Helicobacter pylori infection: first results from the Epidemiological Investigation of Gastric Malignancy (ENIGMA)

Viktoria Knaze, Heinz Freisling, Paz Cook, Katy Heise, Johanna Acevedo, Marcos Cikutovic, Karl-Heinz Wagner, Rodrig Marculescu, Catterina Ferreccio, Rolando Herrero, Jin Young Park

Summary: This study aimed to evaluate the association between salt intake and gastric atrophy (GA) in Chilean adults. The analysis of population-based samples from two sites found little evidence for an association between salt intake and GA risk.

EUROPEAN JOURNAL OF NUTRITION (2023)

Article Gastroenterology & Hepatology

Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response

Benedikt Simbrunner, Esther Caparros, Teresa Neuwirth, Philipp Schwabl, Philipp Koenigshofer, David Bauer, Rodrig Marculescu, Michael Trauner, Bernhard Scheiner, Georg Stary, Mattias Mandorfer, Thomas Reiberger, Ruben Frances

Summary: In patients with advanced chronic liver disease (ACLD), bacterial translocation (BT) leads to systemic inflammation and circulatory dysfunction, but there is no clear correlation between BT markers and portal hypertension and circulatory dysfunction.

HEPATOLOGY INTERNATIONAL (2023)

Article Biochemistry & Molecular Biology

High immunoglobulin-M levels to oxidation-specific epitopes are associated with lower risk of acute myocardial infarction

Adam Taleb, Peter Willeit, Shahzada Amir, Thomas Perkmann, Maria Ozsvar Kozma, Martin L. Watzenboeck, Christoph J. Binder, Joseph L. Witztum, Sotirios Tsimikas

Summary: This study shows that high levels of IgM antibodies to oxidation-specific epitopes (OSEs) may be protective against acute myocardial infarction (AMI) in humans. The levels of IgM OSEs were significantly lower in AMI patients compared to controls. These findings provide important clinical information and support the hypothesis that IgM OSEs have a protective effect against AMI.

JOURNAL OF LIPID RESEARCH (2023)

Article Hematology

Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia

Dino Mehic, Jennifer Machacek, Theresa Schramm, Lisbeth Buresch, Alexandra Kaider, Beate Eichelberger, Helmuth Haslacher, Michael Fillitz, Barbara Dixer, Tanja Flasch, Theresa Anderle, Anja Rath, Alice Assinger, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Summary: This study found that the bleeding phenotype in ITP patients is heterogeneous and usually mild. Platelet reactivity may be one of the factors underlying the mild phenotype.

THROMBOSIS RESEARCH (2023)

Article Oncology

Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial

Maximilian J. Mair, Agnieszka Maj-Hes, Alina Nussbaumer-Proell, Rainer Puhr, Agnieszka Christenheit, Marlene Troch, Hannah C. Puhr, Angelika M. Starzer, Ariane Steindl, Sabine Eberl, Helmuth Haslacher, Thomas Perkmann, Christoph Minichsdorfer, Gerald W. Prager, Wolfgang W. Lamm, Anna S. Berghoff, Barbara Kiesewetter, Markus Zeitlinger, Matthias Preusser, Markus Raderer

Summary: This study aimed to investigate the preventive effect of azithromycin on COVID-19 infection in cancer patients, but due to low acceptance and low incidence of infection, the study was prematurely closed. Nevertheless, azithromycin had a favorable side effect profile in cancer patients.

INFECTIOUS AGENTS AND CANCER (2023)

Article Medicine, General & Internal

The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination

Selma Tobudic, Elisabeth Simader, Thomas Deimel, Jennifer Straub, Felix Kartnig, Leonhard X. Heinz, Peter Mandl, Helmuth Haslacher, Thomas Perkmann, Lisa Schneider, Thomas Nothnagl, Helga Radner, Florian Winkler, Heinz Burgmann, Karin Stiasny, Gottfried Novacek, Walter Reinisch, Daniel Aletaha, Stefan Winkler, Stephan Blueml

Summary: This study aimed to evaluate the duration of humoral responses after two doses of SARS-CoV-2 mRNA vaccines in patients with inflammatory joint diseases and IBD, and to analyze the factors influencing immune response. The results showed that patients receiving b/tsDMARDs had lower antibody levels and neutralizing antibody titers compared to healthy controls or patients receiving csDMARDs. The decline in antibody levels was faster in patients with b/tsDMARDs, indicating a significantly reduced duration of vaccine-induced immunity. Furthermore, they displayed a reduced response to a booster vaccination, highlighting the need for earlier booster strategies in these patients.

FRONTIERS IN MEDICINE (2023)

Article Rheumatology

Associations between nailfold capillary aberrations and autoantibodies in children and adults with Raynaud's phenomenon

Markus Mueller, Michael E. Gschwandtner, Wolfgang Emminger, Hans Kiener, Sebastian Schnaubelt, Georgiana-Aura Giurgea, Robin Ristl, Thomas Perkmann, Renate Koppensteiner, Oliver Schlager

Summary: The objective of this study was to characterize the associations between individual nailfold capillary aberrations and autoantibodies in children and adults with Raynaud's phenomenon (RP). Nailfold capillaroscopy and laboratory tests were conducted on consecutive RP patients without previously known connective tissue disease. The prevalence of nailfold capillary aberrations and antinuclear antibodies (ANA) was assessed and analyzed separately for children and adults, revealing a less pronounced association between nailfold capillary aberrations and ANA in children. Further studies are needed to validate these observations in children with RP.

RMD OPEN (2023)

Article Virology

Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations

Thomas Perkmann, David N. Springer, Patrick Mucher, Michael Wolzt, Lukas Weseslindtner, Helmuth Haslacher

Summary: This study investigated whether breakthrough infection with SARS-CoV-2 Omicron increases antibody levels in individuals who received three doses of wild-type-based BNT162b2 vaccine. The results suggest that breakthrough infection efficiently boosts wild-type antibodies in vaccinated individuals, while antibody levels decrease in those who received only three doses of the vaccine.

JOURNAL OF CLINICAL VIROLOGY (2023)

Article Medicine, General & Internal

Arterial stiffness in acute coronary syndrome as a potential triage tool: a prospective observational study

Sebastian Schnaubelt, Julia Oppenauer, Mathias Bader, Na DU, Felix Eibensteiner, Calvin L. Kienbacher, Enrico Baldi, Markus Mueller, Thomas Perkmann, Helmuth Haslacher, Wolfgang Schreiber, Alexander Niessner, Oliver Schlager, Hans Domanovits, Patrick Sulzgruber

Summary: Pulse-wave velocity (PWV) is a non-invasive measurement that can predict cardiovascular pathologies and PCI complexity in patients with acute coronary syndrome (ACS). This study found that pathological PWV was associated with high-risk prediction scores, cardiac enzymes, and three-vessel disease. Additionally, PWV was also related to the complexity of coronary angiography and PCI procedures.

MINERVA MEDICA (2023)

Article Immunology

The diagnostic and prognostic value of IgG and IgA anti-citrullinated protein antibodies in patients with early rheumatoid arthritis

Daniela Sieghart, Christian Konrad, Sascha Swiniarski, Helmuth Haslacher, Daniel Aletaha, Guenter Steiner

Summary: This study aimed to investigate the diagnostic performance of anti-CCP2 and anti-CCP3 IgG and IgA assays in patients with early RA, with a focus on the prognostic value of IgA ACPA. The results showed that the anti-CCP2 IgG and IgA assays had high specificity but low sensitivity. The anti-CCP3.1 assay had slightly higher sensitivity but lower specificity compared to the anti-CCP2 IgG assay.

FRONTIERS IN IMMUNOLOGY (2023)

No Data Available